Palvella Therapeutics (PVLA) Revenue Growth (5y) (2019 - 2024)
Powered by 
Analysis
Palvella Therapeutics (PVLA) Revenue Growth (5y) (2019 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palvella Therapeutics | 2.24 Bn | 1.93 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -63.82% |
| Dec 31, 2023 | 16.71% |
| Sep 30, 2023 | 18.53% |
| Jun 30, 2023 | 11.43% |
| Mar 31, 2023 | -13.51% |
| Dec 31, 2022 | -20.28% |
| Sep 30, 2022 | 6.46% |
| Jun 30, 2022 | 14.82% |
| Mar 31, 2022 | 52.78% |
| Dec 31, 2021 | 25.37% |
| Sep 30, 2021 | 38.89% |
| Jun 30, 2021 | 25.08% |
| Mar 31, 2021 | 59.82% |
| Dec 31, 2020 | -2.58% |
| Sep 30, 2020 | 47.95% |
| Jun 30, 2020 | 134.01% |
| Mar 31, 2020 | 127.50% |
| Sep 30, 2019 | 48.58% |
| Jun 30, 2019 | 20.82% |